45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.
45 individuals were subdivided into 3 groups, 15 patients suffering from oral premalignant lesions, 15 patients suffering from oral malignant lesions and 15 individuals having age, gender and periodontal status matched with both patients groups acting as a control group. Serum and whole unstimulated saliva samples were collected from all the included groups in order to determine chemerin and MMP-9 in serum and saliva utilizing the ELISA technique.
Study Type
OBSERVATIONAL
Enrollment
45
salivary levels of chemerin in patients with oral premalignant and malignant lesions.
Time frame: 1 day
serum levels of chemerin in patients with oral premalignant and malignant lesions.
Time frame: 1 day
serum levels of MMP-9 in patients with oral premalignant and malignant lesions.
Time frame: morning visit
salivary levels of MMP-9 in patients with oral premalignant and malignant lesions.
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.